124 related articles for article (PubMed ID: 30522558)
61. Enrichment and characterization of cancer stem cells from a human non-small cell lung cancer cell line.
Zhao C; Setrerrahmane S; Xu H
Oncol Rep; 2015 Oct; 34(4):2126-32. PubMed ID: 26239272
[TBL] [Abstract][Full Text] [Related]
62. Oncostatin m renders epithelial cell adhesion molecule-positive liver cancer stem cells sensitive to 5-Fluorouracil by inducing hepatocytic differentiation.
Yamashita T; Honda M; Nio K; Nakamoto Y; Yamashita T; Takamura H; Tani T; Zen Y; Kaneko S
Cancer Res; 2010 Jun; 70(11):4687-97. PubMed ID: 20484035
[TBL] [Abstract][Full Text] [Related]
63. In vitro and in vivo anti-uveal melanoma activity of JSL-1, a novel HDAC inhibitor.
Wang Y; Liu M; Jin Y; Jiang S; Pan J
Cancer Lett; 2017 Aug; 400():47-60. PubMed ID: 28455241
[TBL] [Abstract][Full Text] [Related]
64. Wnt antagonist, secreted frizzled-related protein 4 (sFRP4), increases chemotherapeutic response of glioma stem-like cells.
Warrier S; Balu SK; Kumar AP; Millward M; Dharmarajan A
Oncol Res; 2013; 21(2):93-102. PubMed ID: 24406045
[TBL] [Abstract][Full Text] [Related]
65. Combination of paclitaxel- and retinoic acid-incorporated nanoparticles for the treatment of CT-26 colon carcinoma.
Hong GY; Jeong YI; Lee SJ; Lee E; Oh JS; Lee HC
Arch Pharm Res; 2011 Mar; 34(3):407-17. PubMed ID: 21547672
[TBL] [Abstract][Full Text] [Related]
66. The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance.
Januchowski R; Wojtowicz K; Zabel M
Biomed Pharmacother; 2013 Sep; 67(7):669-80. PubMed ID: 23721823
[TBL] [Abstract][Full Text] [Related]
67. A novel Anti-Cancer Stem Cells compound optimized from the natural symplostatin 4 scaffold inhibits Wnt/β-catenin signaling pathway.
Liu S; Gao X; Zhang L; Qin S; Wei M; Liu N; Zhao R; Li B; Meng Y; Lin G; Lu C; Liu X; Xie M; Liu T; Zhou H; Qi M; Yang G; Yang C
Eur J Med Chem; 2018 Aug; 156():21-42. PubMed ID: 30006166
[TBL] [Abstract][Full Text] [Related]
68. Retinoic acid and ascorbic acid act synergistically in inhibiting human breast cancer cell proliferation.
Kim KN; Pie JE; Park JH; Park YH; Kim HW; Kim MK
J Nutr Biochem; 2006 Jul; 17(7):454-62. PubMed ID: 16443354
[TBL] [Abstract][Full Text] [Related]
69. Global gene expression profiles associated with retinoic acid-induced differentiation of embryonal carcinoma cells.
Eifert C; Sangster-Guity N; Yu LM; Chittur SV; Perez AV; Tine JA; McCormick PJ
Mol Reprod Dev; 2006 Jul; 73(7):796-824. PubMed ID: 16604517
[TBL] [Abstract][Full Text] [Related]
70. Pro-differentiating effects of a synthetic flavagline on human teratocarcinomal cancer stem-like cells.
Emhemmed F; Ali Azouaou S; Zhao Q; Appert-Collin A; Bennasroune A; Schini-Kerth VB; Muller CD; Désaubry L; Fuhrmann G
Cell Biol Toxicol; 2017 Jun; 33(3):295-306. PubMed ID: 27981389
[TBL] [Abstract][Full Text] [Related]
71. Targeting of cancer stem cells by differentiation therapy.
Arima Y; Nobusue H; Saya H
Cancer Sci; 2020 Aug; 111(8):2689-2695. PubMed ID: 32462706
[TBL] [Abstract][Full Text] [Related]
72. Retinoic Acid-Loaded Dendritic Polyglycerol-Conjugated Gold Nanostars for Targeted Photothermal Therapy in Breast Cancer Stem Cells.
Pan Y; Ma X; Liu C; Xing J; Zhou S; Parshad B; Schwerdtle T; Li W; Wu A; Haag R
ACS Nano; 2021 Sep; 15(9):15069-15084. PubMed ID: 34420298
[TBL] [Abstract][Full Text] [Related]
73. The effect of targeted therapy on recruited cancer stem cells in a head and neck carcinoma model.
Marcu LG; Marcu D
Cell Prolif; 2017 Dec; 50(6):. PubMed ID: 28857306
[TBL] [Abstract][Full Text] [Related]
74. Mechanism of drug sensitivity and resistance in melanoma.
La Porta CA
Curr Cancer Drug Targets; 2009 May; 9(3):391-7. PubMed ID: 19442058
[TBL] [Abstract][Full Text] [Related]
75. Crucial role of glucosylceramide synthase in the regulation of stem cell-like cancer cells in B16F10 murine melanoma.
Ghosh S; Juin SK; Bhattacharyya Majumdar S; Majumdar S
Mol Carcinog; 2021 Dec; 60(12):840-858. PubMed ID: 34516706
[TBL] [Abstract][Full Text] [Related]
76. Wilms Tumor NCAM-Expressing Cancer Stem Cells as Potential Therapeutic Target for Polymeric Nanomedicine.
Markovsky E; Vax E; Ben-Shushan D; Eldar-Boock A; Shukrun R; Yeini E; Barshack I; Caspi R; Harari-Steinberg O; Pode-Shakked N; Dekel B; Satchi-Fainaro R
Mol Cancer Ther; 2017 Nov; 16(11):2462-2472. PubMed ID: 28729402
[TBL] [Abstract][Full Text] [Related]
77. Synergy, Additivity and Antagonism between Esculetin and Six Commonly Used Chemotherapeutics in Various Malignant Melanoma Cell Lines-An Isobolographic Analysis.
Wróblewska-Łuczka P; Góralczyk A; Łuszczki JJ
Molecules; 2023 May; 28(9):. PubMed ID: 37175299
[TBL] [Abstract][Full Text] [Related]
78. The role of SOX family in cancer stem cell maintenance: With a focus on SOX2.
Pouremamali F; Vahedian V; Hassani N; Mirzaei S; Pouremamali A; Kazemzadeh H; Faridvand Y; Jafari-Gharabaghlou D; Nouri M; Maroufi NF
Pathol Res Pract; 2022 Mar; 231():153783. PubMed ID: 35121364
[TBL] [Abstract][Full Text] [Related]
79. Targeting cancer stem cells by melatonin: Effective therapy for cancer treatment.
Maroufi NF; Vahedian V; Hemati S; Rashidi MR; Akbarzadeh M; Zahedi M; Pouremamali F; Isazadeh A; Taefehshokr S; Hajazimian S; Seraji N; Nouri M
Pathol Res Pract; 2020 May; 216(5):152919. PubMed ID: 32171553
[TBL] [Abstract][Full Text] [Related]
80. Melanoma cancer stem-like cells: Optimization method for culture, enrichment and maintenance.
Yaiza JM; Gloria RA; María Belén GO; Elena LR; Gema J; Juan Antonio M; María Ángel GC; Houria B
Tissue Cell; 2019 Oct; 60():48-59. PubMed ID: 31582018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
